future glp-1 drugs Changed Obesity Treatment. The Next Challenge May Be Clinical Trial Capacity Patients Face New Barriers for – Heart benefits are erased if

While the clinical translation is still in its early days, the mechanistic rationale is compelling, and the preclinical evidence is impressive

Caruso, R

N.SongR

Evidence suggests that growth hormone secretagogues such as CJC 1295 play an important role in maintaining and improving cardiovascular function, wound healing and repair, increased protein synthesis, and much more

Rosato E, Gigante A, Barbano B, Cianci R, Molinaro I, Rossi C et al

Research indicates that a 5%10% reduction in body weight is sufficient to significantly improve insulin sensitivity, reduce androgen levels, and restore ovulatory function in a subset of patients (19, 20, 31)